Metabolic Syndrome

Cellular Interactions and Immunometabolic Mechanisms in Heart Failure With Preserved Ejection Fraction: From Molecular Mechanisms to Clinical Evidence 2026 Heart Disease and Stroke Statistics Urokinase Plasminogen Activator Deficiency Delays the Development of Obesity and Metabolic Sequelae Exploring Ceramide C16:0 as a Novel Biomarker and Therapeutic Target for Atherosclerosis Addressing the Urgent Cardiometabolic Health Needs Through a Unique Cardiometabolic Fellowship Training Program Impact of GLP-1 Receptor Agonist Therapy on Atrial Fibrillation Recurrence After Catheter Ablation in Obese Patients: A Real-World Data Analysis Unsaturated Fatty Acids to Improve Cardiorespiratory Fitness in Patients With Obesity-Related Heart Failure With Preserved Ejection Fraction: The UFA-Preserved2 Randomized Controlled Crossover Study Unsaturated Fatty Acids to Improve Cardiorespiratory Fitness in Patients With Obesity-Related Heart Failure With Preserved Ejection Fraction: The UFA-Preserved2 Randomized Controlled Crossover Study Key Patient Messages: 2025 Acute Coronary Syndromes Guideline IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes